Power Law company profile

ChemoMetec

Biotech & Life Sciences · Lillerød, Denmark · Founded 1997 · IPO 2006 Unicorn

Develops, manufactures and sells analytical instruments for cell-counting and related workflows in life-science labs

Valuation

$777M

Market cap · May/2026

Revenue

$73M

Latest reported FY

EBITDA

$38M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Global footprint

Where ChemoMetec has talent and traffic

AI talent share

1.5% of workforce is AI talent
(3 of 195 staff)

Core AI00%

Other AI31.54%

Non-AI workforce19298.46%

Workforce by country

7 countries with
team presence

🇩🇰 Denmark66.2%

🇺🇸 United States23.1%

🇬🇧 United Kingdom3.7%

🇩🇪 Germany2.8%

🇨🇳 China2.1%

Top 5 of 7 shown

Patent intelligence

$20M patent portfolio · 24 active families

Estimated portfolio value

$20M

2.6% of market cap · 12.6× smaller than top peer Zealand Pharma ($254M)

24 active patent families

Where ChemoMetec innovates MicroscopeDigital holographic microscopyCellPhysicsLight source

Where ChemoMetec concentrates vs peers

Each axis is a top-10 topic across ChemoMetec and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about ChemoMetec

An AI-synthesized read of the highest-engagement posts about ChemoMetec on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ChemoMetec on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles